{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:22:29Z","timestamp":1791969749972,"version":"4.3.4"},"reference-count":62,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Internet Res"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Over the past 4 decades, obesity has escalated into a global epidemic, with its worldwide prevalence nearly tripling. Pharmacological treatments have evolved with the recent development of glucagon-like peptide 1 agonists, such as semaglutide. However, off-label use of drugs such as Ozempic for cosmetic weight loss has surged in popularity, raising concerns about potential misuse and the emergence of substandard and falsified products in the unregulated supply chain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aims to conduct a multifactor investigation of product quality and patient safety risks associated with the unregulated online sale of semaglutide by examining product availability and vendor characteristics and assessing product quality through test purchases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used a complex risk and quality assessment methodology combining online market surveillance, search engine results page analysis, website content assessment, domain traffic analytics, conducting targeted product test purchases, visual quality inspection of product packaging, microbiological sterility and endotoxin contamination evaluation, and quantitative sample analysis using liquid chromatography coupled with mass spectrometry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We collected and evaluated 1080 links from search engine results pages and identified 317 (29.35%) links belonging to online pharmacies, of which 183 (57.7%) led to legal pharmacies and 134 (42.3%) directed users to 59 unique illegal online pharmacy websites.\u00a0Web traffic data for the period between July and September 2023 revealed that the top 30 domains directly or indirectly affiliated with illegal online pharmacies accumulated over 4.7 million visits.\u00a0Test purchases were completed from\u00a06 illegal online pharmacies with the highest number of links offering semaglutide products for sale without prescription at the lowest price range. Three injection vial purchases were delivered; none of the 3 Ozempic prefilled injection pens were received due to nondelivery e-commerce scams.\u00a0All purchased vials were considered probable substandard and falsified products, as visual inspection indicated noncompliance in more than half (59%-63%) of the evaluated criteria. The semaglutide content of samples substantially exceeded labeled amounts by 28.56%-38.69%, although no peptide-like impurities were identified. The lyophilized peptide samples were devoid of viable microorganisms at the time of testing; however, endotoxin was detected in all samples with levels ranging between 2.1645 EU\/mg and 8.9511 EU\/mg. Furthermore, the measured semaglutide purity was significantly low, ranging between 7.7% and 14.37% and deviating from the 99% claimed on product labels by manufacturers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Glucagon-like peptide 1 agonist drugs promoted for weight loss, similar to erectile dysfunction medications more than 2 decades ago, are becoming the new blockbuster lifestyle medications for the illegal online pharmacy market. Protecting the pharmaceutical supply chain from substandard and falsified weight loss products and raising awareness regarding online medication safety must be a public health priority for regulators and technology platforms alike.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/65440","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T10:45:46Z","timestamp":1730976346000},"page":"e65440","source":"Crossref","is-referenced-by-count":29,"title":["Multifactor Quality and Safety Analysis of Semaglutide Products Sold by Online Sellers Without a Prescription: Market Surveillance, Content Analysis, and Product Purchase Evaluation Study"],"prefix":"10.2196","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0339-5653","authenticated-orcid":false,"given":"Amir Reza","family":"Ashraf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2191-7833","authenticated-orcid":false,"given":"Tim Ken","family":"Mackey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1176-0251","authenticated-orcid":false,"given":"R\u00f3bert Gy\u00f6rgy","family":"Vida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4098-1072","authenticated-orcid":false,"given":"Gy\u0151z\u0151","family":"Kulcs\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3630-9312","authenticated-orcid":false,"given":"J\u00e1nos","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0921-0967","authenticated-orcid":false,"given":"Orsolya","family":"Bal\u00e1zs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6635-4196","authenticated-orcid":false,"given":"B\u00e1lint M\u00e1rk","family":"Domi\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9801-4715","authenticated-orcid":false,"given":"Jiawei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9917-6262","authenticated-orcid":false,"given":"Ibolya","family":"Cs\u00e1k\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8243-6179","authenticated-orcid":false,"given":"Andr\u00e1s","family":"Fittler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2024,11,7]]},"reference":[{"key":"ref1","unstructured":"Obesity and overweightWorld Health Organization2024312024-10-20https:\/\/tinyurl.com\/3mw8bsu3"},{"key":"ref2","unstructured":"Obesity atlas 2023World Obesity Federation Global Obesity Observatory2023-12-27https:\/\/tinyurl.com\/4kd6xdfs"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.ra120000781"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.34"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfx233"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2017.277376"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(17)30236-x"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2014.07.015"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2007.03.006"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0b013e3182825367"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00414-020-02268-2"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7580\/kjlm.2020.44.3.140"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2016-214689"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00414-016-1378-4"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp140034"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/oby.20429"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29262"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.838410"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/asj\/sjad211"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/GOX.0000000000005516"},{"key":"ref21","unstructured":"Shortage of Ozempic (semaglutide)European Medicines Agency202210192024-10-21https:\/\/tinyurl.com\/3mzyt54m"},{"key":"ref22","unstructured":"Drug shortage detail: semaglutide injectionAmerican Society of Health-System Pharmacists2024-02-04https:\/\/tinyurl.com\/ynbb2rrb"},{"key":"ref23","unstructured":"FDA drug shortagesU.S. Food and Drug Administration20223312024-02-04https:\/\/tinyurl.com\/5yc5rjst"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.28280"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.2196\/41834"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2196\/38957"},{"key":"ref27","unstructured":"Council of Europe Convention on the counterfeiting of medical products and similar crimes involving threats to public health (CETS No. 211)Council of Europe2024-08-12https:\/\/tinyurl.com\/3kt3xkcs"},{"key":"ref28","unstructured":"21 USC chapter 9, subchapter III: prohibited acts and penaltiesUnited States Code2024-08-11https:\/\/tinyurl.com\/8rjp5cuc"},{"key":"ref29","unstructured":"FDASIA title VII drug supply chain provisionsU.S. Food & Drug Administration20183282024-08-11https:\/\/tinyurl.com\/4c43e9h7"},{"key":"ref30","unstructured":"Safety and transparency for the commercial internetLegitScript2024-02-09https:\/\/www.legitscript.com\/"},{"key":"ref31","unstructured":"Safe pharmacyNational Association of Boards of Pharmacy2024-02-09https:\/\/safe.pharmacy\/"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2020.10.018"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2023.04.018"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1273540"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e19463"},{"key":"ref36","unstructured":"Tool for visual inspection of medicinesInternational Pharmaceutical Federation2024-10-21https:\/\/tinyurl.com\/bdhmrbva"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1186\/s40545-020-00211-9"},{"key":"ref38","unstructured":"GLS introduces refreshed brand identityGLS20211042024-08-13https:\/\/tinyurl.com\/2ex3vcyn"},{"key":"ref39","unstructured":"Annex I: summary of product characteristicsEuropean Medicines Agency2024-10-21https:\/\/tinyurl.com\/587haax2"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2018.08.037"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2018.06.023"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2024.2026"},{"key":"ref43","unstructured":"US Chem labsU.S. Food and Drug Administration2024272024-10-21https:\/\/tinyurl.com\/bdhhuwdu"},{"key":"ref44","unstructured":"Warning letter: www.semaspace.comU.S. Food and Drug Administration20231022024-01-04https:\/\/tinyurl.com\/ycxnwcdt"},{"key":"ref45","unstructured":"RogueRx activity report: injectable weight loss drugs: how illegal online drug sellers are taking advantage of patientsNational Association of Boards of Pharmacy20242024-10-21https:\/\/tinyurl.com\/yaezzmf4"},{"key":"ref46","unstructured":"FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide productsU.S. Food and Drug Administration20247262024-09-16https:\/\/tinyurl.com\/35dc2shu"},{"key":"ref47","unstructured":"KindelanKSome people are overdosing on semaglutide, FDA warnsABC News20247302024-09-16https:\/\/tinyurl.com\/27tantyu"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.2337\/cd23-0023"},{"key":"ref49","unstructured":"Massy-WestroppMWhat we can learn from the Ozempic shortageThe University of New South Wales, Sydney20232132024-05-27https:\/\/tinyurl.com\/mr45cmsw"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13111503"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1177\/00222437211044472"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.2196\/53086"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18147475"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2011.41.0936"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2015.02.003"},{"key":"ref56","unstructured":"The rise of GLP-1 influencers: celebrity endorsements and social media\u2019s role in the Ozempic weight loss crazeHealthEconomics.com2024252024-08-15https:\/\/tinyurl.com\/5xedfu6y"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.11.016"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.1999"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0203185"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1177\/23992026221074548"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2015.04.022"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-016-0398-y"}],"container-title":["Journal of Medical Internet Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jmir.org\/2024\/1\/e65440","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:58:30Z","timestamp":1785851910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jmir.org\/2024\/1\/e65440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,7]]},"references-count":62,"URL":"https:\/\/doi.org\/10.2196\/65440","relation":{"has-preprint":[{"id-type":"doi","id":"10.2196\/preprints.65440","asserted-by":"object"}]},"ISSN":["1438-8871"],"issn-type":[{"value":"1438-8871","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,7]]}}}